VCAM-1 mRNA expression levels resulted in significantly reduced TNF-α stimulated C- and GDM-HUVEC after pre-treatment with AEO (Figure 5a and Figure 5b, respectively) and LEO (Figure 5c and Figure 5d, respectively). This evidence concerns the gene VCAM1 and gestational diabetes.